Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChampions Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2024 | 1 | $0.01 | $0.01 | $0.01 |
| Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | $0.06 | $0.06 | $0.06 |
| Q3 2025 | 1 | $0.06 | $0.06 | $0.06 |
| Q4 2025 | 1 | $0.08 | $0.08 | $0.08 |
| Q1 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q2 2026 | 1 | $0.08 | $0.08 | $0.08 |
Champions Oncology, Inc. Earnings Date And Information
Champions Oncology, Inc. last posted its earnings results on Wednesday, December 11th, 2024. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.04. The company had revenue of 13.49 M for the quarter and had revenue of 50.16 M for the year. Champions Oncology, Inc. has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -189.81. Champions Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Champions Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/16/2024 | Q2 2025 | $0.05 | $13.05 M | $13.49 M | ||
| 09/13/2024 | Q1 2025 | $0.10 | $13.23 M | $14.06 M | ||
| 07/19/2024 | Q4 2024 | -$0.01 | $14.00 M | |||
| 03/14/2024 | Q3 2024 | -$0.19 | $13.50 M | $12.02 M | ||
| 12/13/2023 | Q2 2024 | -$0.15 | $12.82 M | $11.57 M | ||
| 09/13/2023 | Q1 2024 | -$0.10 | -$0.19 | -0.09 | $13.10 M | $12.56 M |
| 07/24/2023 | Q4 2023 | -$0.12 | -$0.19 | -0.07 | $13.07 M | |
| 03/16/2023 | Q3 2023 | -$0.18 | $13.13 M | $12.77 M | ||
| 12/13/2022 | Q2 2023 | -$0.00 | -$0.00 | -0 | $13.79 M | $14.28 M |
| 09/12/2022 | Q1 2023 | -$0.02 | $13.46 M | $13.75 M | ||
| 07/22/2022 | Q4 2022 | -$0.03 | $12.88 M | |||
| 03/15/2022 | Q3 2022 | $0.03 | $0.06 | 0.04 | $13.03 M | $13.19 M |
| 12/13/2021 | Q2 2022 | $0.01 | $0.02 | 0.02 | $11.67 M | $11.79 M |
| 09/13/2021 | Q1 2022 | -$0.00 | -$0.01 | -0.01 | $11.13 M | $11.25 M |
| 07/26/2021 | Q4 2021 | -$0.04 | $10.57 M | |||
| 03/15/2021 | Q3 2021 | $0.07 | $10.14 M | $10.81 M | ||
| 12/14/2020 | Q2 2021 | $0.01 | $0.00 | -0.01 | $9.81 M | $10.12 M |
| 09/14/2020 | Q1 2021 | $0.02 | $0.01 | -0.01 | $8.88 M | $9.55 M |
| 07/28/2020 | Q4 2020 | -$0.17 | $8.75 M | |||
| 03/16/2020 | Q3 2020 | $0.03 | $9.01 M | $9.01 M |
Champions Oncology, Inc. Earnings: FAQ's
When is Champions Oncology, Inc.'s earnings date?
Champions Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates.
Did Champions Oncology, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Champions Oncology, Inc. (:CSBR) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.04.
How can I listen to Champions Oncology, Inc.'s earnings conference
call?
The conference call for Champions Oncology, Inc.'s latest earnings report can be listened to online.
How can I read Champions Oncology, Inc.'s conference call transcript?
The conference call transcript for Champions Oncology, Inc.'s latest earnings report can be read online.
How much revenue does Champions Oncology, Inc. generate each year?
Champions Oncology, Inc. (:CSBR) has a recorded annual revenue of $50.16 M.
How much profit does Champions Oncology, Inc. generate each year?
Champions Oncology, Inc. (:CSBR) has a recorded net income of $50.16 M. Champions Oncology, Inc. has generated $-0.54 earnings per share over the last four quarters.
What is Champions Oncology, Inc.'s price-to-earnings ratio?
Champions Oncology, Inc. (:CSBR) has a price-to-earnings ratio of -189.81 and price/earnings-to-growth ratio is -9.49.